Pfizer News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

31.10.23	Pfizer Inc. Q3 Earnings Summary (RTTNews)
31.10.23	Pfizer Reports Third-Quarter 2023 Results (Businesswire)
26.10.23	Pfizer Reports Positive Data For MRNA-based Combination Vaccine Program Against Influenza & COVID-19 (RTTNews)
26.10.23	Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 (Businesswire)
25.10.23	Pfizer To Expand Access To Cadence Products And Programming Toolkits For Advanced Molecular Design (RTTNews)
20.10.23	Pfizer Secures FDA Approval For Penbraya (RTTNews)
20.10.23	FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents (Businesswire)
16.10.23	Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis (PR Newswire)
16.10.23	Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023 (PR Newswire)
13.10.23	Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance (Businesswire)
13.10.23	Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis (RTTNews)
12.10.23	Pfizer: FDA Approves BRAFTOVI + MEKTOVI In Treatment Of Metastatic NSCLC With BRAF V600E Mutation (RTTNews)
12.10.23	U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer (Businesswire)
05.10.23	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases (Businesswire)
04.10.23	Pfizer Declares Fourth-Quarter 2023 Dividend (Businesswire)
03.10.23	Pfizer's Hospira Recalls Sodium Bicarbonate, Lidocaine HCl Injections (RTTNews)
27.09.23	Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer (PR Newswire)
26.09.23	Pfizer Plant In North Carolina Restarts Production After Tornado Damage (RTTNews)
23.09.23	CDC Recommends Pfizer's Vaccine 'Abrysvo' To Help Protect Babies Against Severe RSV Illness (RTTNews)
22.09.23	Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV (Businesswire)
19.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
19.09.23	Pfizer's LITFULO To Treat Severe Alopecia Areata Gets Approval In EU (RTTNews)
19.09.23	GSK : EC Authorizes ViiV Healthcare's Apretude For HIV Prevention (RTTNews)
19.09.23	European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata (Businesswire)
18.09.23	Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts (Businesswire)
13.09.23	CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine (RTTNews)
13.09.23	European Medicines Agency Validates Type II Variation for Astellas' XTANDI® (enzalutamide) for Treatment of Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (PR Newswire)
12.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
12.09.23	FDA Approves Pfizer-BioNTech's Updated COVID-19 Vaccine (RTTNews)
11.09.23	Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine (Businesswire)
05.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
30.08.23	Pfizer, BioNTech Obtain Positive CHMP Opinion For Omicron XBB.1.5-adapted COVID-19 Vaccine In EU (RTTNews)
30.08.23	Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences (Businesswire)
30.08.23	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union (Businesswire)
25.08.23	EU Approves Pfizer' Abrysvo To Help Protect Infants And Older Adults From RSV (RTTNews)
24.08.23	European Commission Approves Pfizer’s ABRYSVO™ to Help Protect Infants through Maternal Immunization and Older Adults from RSV (Businesswire)
24.08.23	Everest Medicines Announces Interim Results for First Half of 2023 (PR Newswire)
23.08.23	Pfizer, Astellas' XTANDI Gets Priority Review In Non-metastatic Castration-sensitive Prostate Cancer (RTTNews)
23.08.23	FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence (PR Newswire)
22.08.23	FDA Approves Pfizer's Abrysvo For Pregnant Individuals To Prevent RSV In Infants (RTTNews)
21.08.23	U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age (Businesswire)
14.08.23	Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma (Businesswire)
04.08.23	Pfizer Faces Distribution Restrictions Following Tornado Damage To North Carolina Plant (RTTNews)
01.08.23	Pfizer Reaffirms FY23 Adj. EPS Outlook - Update (RTTNews)
01.08.23	Pfizer Inc. Q2 Profit Decreases, but beats estimates (RTTNews)
01.08.23	Pfizer Reports Second-Quarter 2023 Results (Businesswire)
31.07.23	Biotech Stocks Facing FDA Decision In August 2023 (RTTNews)
28.07.23	AstraZeneca Q2 Profit Surges, Signs Gene Therapy Deal With Pfizer; Stock Up (RTTNews)
27.07.23	Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy (Businesswire)
21.07.23	Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	137.35	1.40 %	K V
Sonova Hldg	297.30	1.29 %	K V
Logitech Intl	74.86	1.22 %	K V
Nestle	75.22	1.02 %	K V
Alcon	76.32	0.95 %	K V
UBS Group	28.17	-0.67 %	K V
Swiss Re	131.95	-0.68 %	K V
Geberit	533.80	-0.78 %	K V
Lonza Grp	541.40	-0.81 %	K V
Kuehne+Nagel Int	202.60	-1.65 %	K V

mehr

17.12.24		Schwacher Handel in New York: Dow Jones schliesst im Minus
17.12.24		Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein
17.12.24		Schwache Performance in New York: S&P 500 beendet den Handel im Minus
17.12.24		Pfizer-Aktie unverändert: Umsatz auf Vorjahreshöhe für 2025 geplant
17.12.24		Dow Jones-Handel aktuell: Dow Jones mit Abgaben
17.12.24		Anleger in New York halten sich zurück: S&P 500 präsentiert sich nachmittags leichter
17.12.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite notiert nachmittags im Minus
17.12.24		Minuszeichen in New York: Dow Jones am Mittag schwächer